Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NutropinAq IGF-I generation test in short children with low IGF-I
2010-019980-13Phase 4Terminated
- Sponsor
- Ipsen
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in Idiopathic Short Stature (ISS), sponsored by Ipsen. Primary endpoints: Predictive value of peak IGF-I SDS after 2 weeks and Predictive value of other IGF-I generation test parameters. Started Jul 2011; status: terminated.
02
Drugs
somatropin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on 2010-019980-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019980-13.